GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (NAS:HCM) » Definitions » Float Percentage Of Total Shares Outstanding

HUTCHMED (China) (HUTCHMED (China)) Float Percentage Of Total Shares Outstanding : 0.00% (As of Apr. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is HUTCHMED (China) Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, HUTCHMED (China)'s float shares is 0.00 Mil. HUTCHMED (China)'s total shares outstanding is 170.73 Mil. HUTCHMED (China)'s float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, HUTCHMED (China)'s Insider Ownership is 2.75%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, HUTCHMED (China)'s Institutional Ownership is 4.18%.

HUTCHMED (China) Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

HUTCHMED (China)'s Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/170.73
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HUTCHMED (China) (HUTCHMED (China)) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (NAS:HCM) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
LSE:INDV LSE:BMK LSE:HIK LSE:APH LSE:AGY LSE:ANCR LSE:EAH LSE:VLG LSE:CEL LSE:STX ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA TSE:4507 VTRS NBIX XSWX:SDZ
Traded in Other Exchanges
00013:Hong Kong HCM.GB:UK HCM:UK H7T2:Germany
Address
2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG
Website
https://www.hutch-med.com
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.